On Friday, VolitionRX Ltd (AMEX: VNRX) opened higher 5.12% from the last session, before settling in for the closing price of $0.66. Price fluctuations for VNRX have ranged from $0.40 to $0.94 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 5.38% annually for the last half of the decade. Company’s average yearly earnings per share was noted 43.55% at the time writing. With a float of $78.84 million, this company’s outstanding shares have now reached $103.98 million.
VolitionRX Ltd (VNRX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of VolitionRX Ltd is 26.72%, while institutional ownership is 22.29%. The most recent insider transaction that took place on Aug 05 ’25, was worth 50,000. In this transaction Director of this company bought 78,125 shares at a rate of $0.64, taking the stock ownership to the 966,814 shares. Before that another transaction happened on Aug 05 ’25, when Company’s President and CEO bought 78,125 for $0.64, making the entire transaction worth $50,000. This insider now owns 2,609,847 shares in total.
VolitionRX Ltd (VNRX) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.07 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.06) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 43.55% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Check out the current performance indicators for VolitionRX Ltd (VNRX). In the past quarter, the stock posted a quick ratio of 0.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 56.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.16 million. That was inferior than the volume of 0.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 36.71%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 54.12%, which indicates a significant decrease from 55.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0457 in the past 14 days, which was lower than the 0.0583 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7024, while its 200-day Moving Average is $0.6111. However, in the short run, VolitionRX Ltd’s stock first resistance to watch stands at $0.7067. Second resistance stands at $0.7233. The third major resistance level sits at $0.7567. If the price goes on to break the first support level at $0.6567, it is likely to go to the next support level at $0.6233. The third support level lies at $0.6067 if the price breaches the second support level.
VolitionRX Ltd (AMEX: VNRX) Key Stats
There are currently 107,595K shares outstanding in the company with a market cap of 74.24 million. Presently, the company’s annual sales total 1,230 K according to its annual income of -26,970 K. Last quarter, the company’s sales amounted to 410 K and its income totaled -6,280 K.
